Gemphire Therapeutics Inc. License Agreements
3 Contracts & Agreements
- License Agreement, between by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022 (Filed With SEC on September 14, 2022)
- License Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019 (Filed With SEC on September 3, 2019)
- Amended and Restated License Agreement effective August 2, 2018 by and between Gemphire Therapeutics Inc. and Pfizer Inc (Filed With SEC on August 6, 2018)
